ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026
Defect-Rich 2D Layered Double Hydroxides Enhance Sonodynamic Antibacterial Therapy.
Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- ROS-Balancing MXene/MoSeSmall (Weinheim an der Bergstrasse, Germany) · 2026Article
- Sonodynamic CoMg-Quercetin Nanozyme for Antibacterial Therapy and Multifunctional Bone Regeneration in Infectious Bone Defects.Biomaterials research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Sonodynamic Therapy (SDT) is a non-invasive therapeutic strategy for combating antibiotic-resistant infections. However, current sonosensitizers typically show limited reactive oxygen species (ROS) output under ultrasound (US) irradiation. While layered double hydroxides (LDHs) feature tunable architectures and favorable biocompatibility for biomedical applications, their potential in SDT-driven antibacterial systems remains underexplored. Here, we introduce a defect engineering paradigm based on a facile acid-etching method to construct defect-rich 2D DR-ZnCuW-LDH nanosheets. This ambient-condition approach enables flexible defect-phase engineering without energy-intensive processing. Through this straightforward treatment, the nanosheets undergo a crystalline-to-polycrystalline phase transition, form abundant defects with oxygen vacancies (OVs), and narrow the bandgap (Eg) from 3.29 to 1.80 eV, thereby markedly improving electron-hole separation. Remarkably, DR-ZnCuW-LDH nanosheets exhibit a fourfold increase in ROS generation under US irradiation compared to pristine ZnCuW-LDH, significantly enhancing its performance as an inorganic sonosensitizer for antibacterial applications. This substantial improvement stems from strategically introduced defects and the phase transformation-induced electronic structure modification. Both in vitro and in vivo evaluations validate the exceptional antibacterial efficacy of DR-ZnCuW-LDH nanosheets under US, establishing a versatile platform for sonodynamic antibacterial applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.